Old Bisantrene (RC110) was approved in France just not commercialized that was a corporate decision. Pretty sure that means it was successful. The mechanisms of action were not as well understood and they are now being uncovered as well as an expanded addressable market. DYOR. Have the original poster on ignore.....
Q. Bisantrene is not new. How can RAC monetise if it is out of patent?, page-150
-
- There are more pages in this discussion • 242 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.54 |
Change
-0.015(0.97%) |
Mkt cap ! $261.5M | |||
| Open | High | Low | Value | Volume |
| $1.55 | $1.55 | $1.50 | $111.4K | 73.35K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 500 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.56 | 1400 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| RAC (ASX) Chart |